Heart rhythm monitoring after non-heart surgery to find atrial fibrillation
Tests a wearable heart monitor worn for up to 14 days after surgery.
Plain-language title generated from the registry record
Registry title: DETECTion of PeriOperative Atrial Fibrillation After Noncardiac Surgery
Key facts
- Where
- Hamilton, London, Sherbrooke, and St. Catharines, CanadaSee the 6 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 120 years old?
Source: NCT06519747, who can take part
Where in Canada
- Hamilton General HospitalHamilton, CanadaTaking people
- Juravinski HospitalHamilton, CanadaTaking people
- St. Joseph's Healthcare HamiltonHamilton, CanadaNot yet recruiting
- London Health Sciences Centre, University HospitalLondon, CanadaNot yet recruiting
- Hôpital Fleurimont du Centre hospitalier universitaire de SherbrookeSherbrooke, CanadaNot yet recruiting
- Niagara Health System - St. Catharine's SiteSt. Catharines, CanadaNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Population Health Research Institute
- Trial code
- NCT06519747
- Record updated
- 7 November 2024
- Original description
This is a multicentre prospective cohort study where patients will receive up to 14 days of continuous ECG monitoring by wearing a portable monitoring device, starting within 72 hours after noncardiac surgery.Read full original descriptionShow less
Enhanced DETECTion of PeriOperative Atrial Fibrillation After Noncardiac Surgery with Continuous Electrocardiographic Monitoring
This is a multicentre prospective cohort study where patients will receive up to 14 days of continuous ECG monitoring by wearing a portable monitoring device, starting within 72 hours after noncardiac surgery.
Inclusion: Had undergone noncardiac surgery within the past 72 hours and requiring, or expected to require, at least one of the following:; an overnight hospital admission after surgery; day surgery that would result in a large enough physiological insult to be able to cause POAF. Procedures excluded include those that are conducted using local anesthesia alone, are less than 30 minutes in duration, and/or are judged to be of low physiologic insult by the local investigator; Have one of the following high-risk criteria; age 55-64 years, and having either established cardiovascular disease, recent major vascular surgery, a CHA2DS2-VASc score ≥3, or an elevated postoperative troponin level; age 65-74 years, and having either established cardiovascular disease, recent major vascular surgery, a CHA2DS2-VASc score ≥2, or an elevated postoperative troponin level; or; age ≥75 years; Provide written informed consent to participate.
Exclusion: Known life expectancy <1 year due to concomitant disease; Previously enrolled in DETECT-POAF; History of documented chronic (i.e., non-transient) AF before noncardiac surgery; Severe renal insufficiency; Acute stroke in the past 14 days; Underwent cardiac surgery in the past 35 days; History of nontraumatic intracranial, intraocular, or spinal bleeding; Hemorrhagic disorder or bleeding diathesis; Known contact allergy to monitoring device and/or its peripheral components; Need for long-term systemic anticoagulation; Ongoing need for long-term dual antiplatelet treatment; Contraindication to oral anticoagulation; Severe liver cirrhosis; Women who are pregnant, breastfeeding, or of childbearing potential not taking effective contraception; Expected to be non-compliant with follow-up and/or device use.